Atlas Trials

A Study to Assess the Safety and Efficacy of 7 Days Treatment With a Novel Analgesic in Subjects With Peripheral Neuropathic Pain

Clinical trial NCT01485094 · TERMINATED

Trial details

NCT number
NCT01485094
Sponsor
Grünenthal GmbH
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Neuralgia
Start date
2012-02-01
Primary completion
2013-01-01
Enrollment
114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.